1. Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors. Issue 8 (8th February 2017) Authors: Peverelli, E.; Giardino, E; Treppiedi, D.; Meregalli, M.; Belicchi, M.; Vaira, V.; Corbetta, S.; Verdelli, C.; Verrua, E.; Serban, A. L.; Locatelli, M.; Carrabba, G.; Gaudenzi, G.; Malchiodi, E.; Cassinelli, L.; Lania, A. G.; Ferrero, S.; Bosari, S.; Vitale, G.; Torrente, Y. Journal: International journal of cancer Issue: Volume 140:Issue 8(2017:Apr. 15) Page Start: 1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗